Structural Basis for differential neutralization of ebolaviruses

Viruses

Volumn 4, Issue 4, 2012, Pages 447-470

  Bale, Shridhar ^a   Dias, Joao M ^a,e   Fusco, Marnie L ^a   Hashiguchi, Takao ^a   Wong, Anthony C ^b   Liu, Tong ^c   Keuhne, Ana I ^d   Li, Sheng ^c   Woods, Virgil L ^c   Chandran, Kartik ^b   Dye, John M ^d   Saphire, Erica Ollmann ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^e Heptares Therapeutics Ltd   (United Kingdom)

Author keywords

Antibodies; Ebola; Ebolavirus; Filovirus; Neutralization: glycoprotein; Structure; Sudan virus

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 1; GLYCOPROTEIN GP 1,2; GLYCOPROTEIN GP 2; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; EBOLA VIRUS; NONHUMAN; PROTEIN STRUCTURE; SUDAN VIRUS; SURFACE PLASMON RESONANCE; THERMODYNAMICS; VIRUS NEUTRALIZATION;

ANIMALIA; EBOLA VIRUS; MARBURGVIRUS; PRIMATES;

EID: 84860231517     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v4040447     Document Type: Article

References (32)

1. Sanchez, A.; Khan, A.S.; Zaki, S.R.; Nabel, G.J.; Ksiazek, T.G.; Peters, C.J. Filoviridae: Marburg and Ebola viruses. In Fields Virology, Knipe, D. M.; Howley, P. M., Eds. Lippincott, Williams, and Wilkins: Philadelphia, 2001; pp 1279-1304.
2. Towner, J.S.; Sealy, T.K.; Khristova, M.L.; Albarino, C.G.; Conlan, S.; Reeder, S.A.; Quan, P.L.; Lipkin, W.I.; Downing, R.; Tappero, J.W.; Okware, S.; Lutwama, J.; Bakamutumaho, B.; Kayiwa, J.; Comer, J.A.; Rollin, P.E.; Ksiazek, T.G.; Nichol, S.T. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008, 4, e1000212.
3. World Health Organization, International Commission to Sudan: Ebola Hemorrhagic Fever in Sudan, 1976. Bulletin of the World Health Organization 1978, 56, 247-270.
4. Sanchez, A.; Rollin, P.E. Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda. Virus Res. 2005, 113, 16-25.
5. Maruyama, T.; Parren, P.W.; Sanchez, A.; Rensink, I.; Rodriguez, L.L.; Khan, A.S.; Peters, C.J.; Burton, D.R. Recombinant human monoclonal antibodies to Ebola virus. J. Infect. Dis. 1999, 179 Suppl 1, S235-239.
6. Gupta, M.; Mahanty, S.; Bray, M.; Ahmed, R.; Rollin, P.E. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J. Virol. 2001, 75, 4649-54.
7. Wilson, J.A.; Hevey, M.; Bakken, R.; Guest, S.; Bray, M.; Schmaljohn, A.L.; Hart, M.K. Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000, 287, 1664-1666.
8. Parren, P.W.H.I.; Geisbert, T.W.; Maruyama, T.; Jahrling, P.B.; Burton, D.R. Preand postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J. Virol. 2002, 76, 6408-6412.
9. Oswald, W.B.; Geisbert, T.W.; Davis, K.J.; Geisbert, J.B.; Sullivan, N.J.; Jahrling, P.B.; Parren, P.W.; Burton, D.R. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog. 2007, 3, 62-66.
10. Jahrling, P.B.; Geisbert, J.B.; Swearengen, J.R.; Larsen, T.; Geisbert, T.W. Ebola Hemorrhagic Fever: Evaluation of Passive Immunotherapy in Nonhuman Primates. J. Infect. Dis. 2007, 196, 400-403.
11. Dye, J.M.; Herbert, A.S.; Kuehne, A.I.; Barth, J.F.; Muhammad, M.A.; Zak, S.E.; Ortiz, R.A.; Prugar, L.I.; Pratt, W.D. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl. Acad. Sci. USA 2012.
12. Lee, J.E.; Fusco, M.H.; Hessell, A.J.; Oswald, W.B.; Burton, D.R.; Saphire, E.O. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008, 454, 177-183.
13. Weissenhorn, W.; Calder, L.J.; Wharton, S.A.; Skehel, J.J.; Wiley, D.C. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triplestranded coiled coil. Proc. Natl. Acad. Sci. USA 1998, 95, 6032-6036.
14. Weissenhorn, W.; Carfi, A.; Lee, K.H.; Skehel, J.J.; Wiley, D.C. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell 1998, 2, 605-616.
15. Malashkevich, V.N.; Schneider, B.J.; McNally, M.L.; Milhollen, M.A.; Pang, J.X.; Kim, P.S. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution. Proc. Natl. Acad. Sci. USA 1999, 96, 2662-2667.
16. Dias, J.M.; Kuehne, A.I.; Abelson, D.M.; Bale, S.; Wong, A.C.; Halfmann, P.; Muhammad, M.A.; Fusco, M.L.; Zak, S.E.; Kang, E.; Kawaoka, Y.; Chandran, K.; Dye, J.M.; Saphire, E.O. A shared structural solution for neutralizing ebolaviruses. Nat. Struct. Mol. Biol. 2011, 18, 1424-1427.
17. Bale, S.; Liu, T.; Li, S.; Wang, Y.; Abelson, D.; Fusco, M.; Woods, V.L., Jr.; Ollmann Saphire, E. Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion. PLoS Negl. Trop. Dis. 2011, 5, e1395.
18. Misasi, J.; Chandran, K.; Yang, J.Y.; Considine, B.; Filone, C.M.; Cote, M.; Sullivan, N.; Fabozzi, G.; Hensley, L.; Cunningham, J. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J. Virol. 2012, 86, 3284-3292.
19. Gnirss, K.; Kuhl, A.; Karsten, C.; Glowacka, I.; Bertram, S.; Kaup, F.; Hofmann, H.; Pohlmann, S. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology 2012, 424, 3-10.
20. Delos, S.E.; La, B.; Gilmartin, A.; White, J.M. Studies of the chain reversal regions of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry. J. Virol. 2010, 84, 5687-5694.
21. Dube, D.; Brecher, M.B.; Delos, S.E.; Rose, S.C.; Park, E.W.; Schornberg, K.L.; Kuhn, J.H.; White, J.M. The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J. Virol. 2009, 83, 2883-2891.
22. Schornberg, K.; Matsuyama, S.; Kabsch, K.; Delos, S.; Bouton, A.; White, J. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 2006, 80, 4174-4178.
23. Brecher, M.B.; Schornberg, K.L.; Delos, S.E.; Fusco, M.L.; Saphire, E.O.; White, J.M. Cathepsin Cleavage Potentiates the Ebola Virus Glycoprotein to Undergo a Fusion Relevant Conformational Change. J. Virol. 2011, in press.
24. Yang, Z.Y.; Duckers, H.J.; Sullivan, N.J.; Sanchez, A.; Nabel, E.G.; Nabel, G.J. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 2000, 6, 886-889.
25. Otwinowski, Z.; Minor, W. Processing of X-ray Diffraction Data Collected in Oscillation Mode. Meth. Enzymol. 1997, 276A, 307-326.
26. McCoy, A.J.; Grosse-Kunstleve, R.W.; Storoni, L.C.; Read, R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 2005, 61, 458-464.
27. Yokota, A.; Tsumoto, K.; Shiroishi, M.; Kondo, H.; Kumagai, I. The role of hydrogen bonding via interfacial water molecules in antigen-antibody complexation. The HyHEL-10-HEL interaction. J. Biol. Chem. 2003, 278, 5410-5418.
28. Brünger, A.T.; Adams, P.D.; Clore, G.M.; DeLano, W.L.; Gros, P.; Grosse-Kunstleve, R.W.; Jiang, J.S.; Kuszewski, J.; Nilges, M.; Pannu, N.S.; Read, R.J.; Rice, L.M.; Simonson, T.; Warren, G.L. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. 1998, D54, 905-921.
29. Emsley, P.; Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. 2004, D60, 2126-2132.
30. Adams, P.D.; Grosse-Kunstleve, R.W.; Hung, L.W.; Ioerger, T.R.; McCoy, A.J.; Moriarty, N.W.; Read, R.J.; Sacchettini, J.C.; Sauter, N.K.; Terwilliger, T.C. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. 2002, D58, 1948-1954.
31. Takada, A.; Robison, C.; Goto, H.; Sanchez, A.; Murti, K.G.; Whitt, M.A.; Kawaoka, Y. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA 1997, 94, 14764-14769.
32. Wong, A.C.; Sandesara, R.G.; Mulherkar, N.; Whelan, S.P.; Chandran, K. A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. J. Virol. 2010, 84, 163-175.